BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Gilteritinib

Differentiation Syndrome

  • Patients treated with XOSPATA have experienced symptoms of differentiation syndrome, which can be fatal or life-threatening if not treated. Symptoms may include fever, dyspnea, hypoxia, pulmonary infiltrates, pleural or pericardial effusions, rapid weight gain or peripheral edema, hypotension, or renal dysfunction. If differentiation syndrome is suspected, initiate corticosteroid therapy and hemodynamic monitoring until symptom resolution

Patient Counseling Information

Medication Guides

Patient Medication Guide - XOSPATA

Package Inserts

Gilteritinib

Additional Information

Updated June 2019